Recognize Comorbid Fibromyalgia Syndrome in Order to Better Evaluate Selected Rheumatic Diseases
Reference84 articles.
1. Carr A, Hewlett S, Hughes R, Mitchell H, Ryan S, Carr M, et al. Rheumatology outcomes: The patient’s perspective. Journal of Rheumatology. 2003;30:880-883
2. Lee YC, Bingham CO, Edwards RR, et al. Pain sensitization is associated with disease activity in rheumatoid arthritis patients: A cross-sectional study. Arthritis Care Research (Hobogen). Dec 2017;69(12):1871-1877. DOI: 10.1002/acr.23266. [Epub ahead of print]
3. Matcham F, Ali S, Irving K, et al. Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study. BMC Musculoskeletal Disorders. 2016;17(155). The authors analyzed the effects of depression and anxiety on the DAS28 in 56 RA patients followed prospectively for 1 year. “After adjusting for age, gender, disease duration and baseline tender joint count and patient global assessment respectively, higher levels of depression and anxiety at baseline were associated with increased tender joint count and patient global assessment scores at 1-year follow-up.”
4. Wolfe F. The relation between tender points and fibromyalgia symptom variables: Evidence that fibromyalgia is not a discrete disorder. Annals of the Rheumatic Disorders. 1997;56:268-271
5. Atzeni F, Cazzola M, Benucci M, et al. Chronic widespread pain in the spectrum of rheumatological diseases. Best Practice Research and Clinic Rheumatology. 2011;25:165-171. FMS (1990 ACR) is often associated with other diseases that act as confounding and aggravating factors, including primary Sjögren’s syndrome (pSS), systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). It has been reported to coexist in 25% of patients with RA, 30% of patients with SLE and 50% of patients with pSS. It is associated with diminished QoL